CAN
IHE icon

Cetera Advisor Networks’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Cetera Advisor Networks’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$536K Buy
7,889
+521
+7% +$34.4K ﹤0.01% 1888
2023
Q4 		$455K Buy
7,368
+9
+0.1% +$529 ﹤0.01% 1958
2023
Q3 		$434K Hold
7,359
– – ﹤0.01% 1868
2023
Q2 		$439K Hold
7,359
– – ﹤0.01% 1805
2023
Q1 		$430K Buy
7,359
+264
+4% +$15.9K ﹤0.01% 1806
2022
Q4 		$440K Sell
7,095
-186
-3% -$11.2K ﹤0.01% 1732
2022
Q3 		$411K Buy
7,281
+813
+13% +$50.1K 0.01% 1414
2022
Q2 		$413K Buy
6,468
+45
+0.7% +$2.86K 0.01% 1402
2022
Q1 		$416K Sell
6,423
-204
-3% -$12.9K 0.01% 1420
2021
Q4 		$441K Buy
6,627
+204
+3% +$12.9K 0.01% 1349
2021
Q3 		$392K Sell
6,423
-186
-3% -$11.8K 0.01% 1362
2021
Q2 		$409K Sell
6,609
-534
-7% -$32.5K 0.01% 1312
2021
Q1 		$423K Buy
7,143
+600
+9% +$36.2K 0.01% 960
2020
Q4 		$391K Sell
6,543
-453
-6% -$25.8K 0.01% 907
2020
Q3 		$381K Sell
6,996
-1,806
-21% -$97.4K 0.01% 818
2020
Q2 		$452K Sell
8,802
-1,209
-12% -$60.8K 0.01% 738
2020
Q1 		$449K Sell
10,011
-5,733
-36% -$289K 0.01% 648
2019
Q4 		$842K Sell
15,744
-1,122
-7% -$55.3K 0.02% 549
2019
Q3 		$785K Sell
16,866
-7,635
-31% -$366K 0.02% 529
2019
Q2 		$1.23M Sell
24,501
-4,842
-17% -$239K 0.04% 389
2019
Q1 		$1.5M Sell
29,343
-93
-0.3% -$4.63K 0.05% 307
2018
Q4 		$1.38M Sell
29,436
-1,302
-4% -$66.7K 0.05% 298
2018
Q3 		$1.72M Buy
30,738
+1,185
+4% +$64.8K 0.06% 274
2018
Q2 		$1.49M Buy
29,553
+492
+2% +$24.4K 0.07% 229
2018
Q1 		$1.43M Sell
29,061
-987
-3% -$50.7K 0.06% 252
2017
Q4 		$1.55M Sell
30,048
-1,221
-4% -$62.7K 0.06% 256
2017
Q3 		$1.63M Sell
31,269
-396
-1% -$20.3K 0.07% 226
2017
Q2 		$1.64M Sell
31,665
-408
-1% -$20.6K 0.08% 226
2017
Q1 		$1.62M Sell
32,073
-1,125
-3% -$55.7K 0.08% 229
2016
Q4 		$1.57M Sell
33,198
-11,124
-25% -$528K 0.08% 218
2016
Q3 		$2.21M Buy
44,322
+5,835
+15% +$296K 0.08% 216
2016
Q2 		$1.85M Sell
38,487
-1,632
-4% -$77.7K 0.11% 194
2016
Q1 		$1.83M Sell
40,119
-4,296
-10% -$201K 0.11% 181
2015
Q4 		$2.4M Buy
44,415
+1,371
+3% +$72.1K 0.15% 148
2015
Q3 		$2.12M Buy
43,044
+7,632
+22% +$437K 0.15% 150
2015
Q2 		$2.03M Hold
35,412
– – 0.13% 168
2015
Q1 		$2.03M Buy
35,412
+3,408
+11% +$186K 0.13% 168
2014
Q4 		$1.61M Buy
32,004
+4,692
+17% +$229K 0.11% 187
2014
Q3 		$1.28M Buy
27,312
+3,384
+14% +$153K 0.09% 231
2014
Q2 		$1.08M Buy
23,928
+4,902
+26% +$211K 0.07% 286
2014
Q1 		$800K Buy
19,026
+1,023
+6% +$42.9K 0.06% 321
2013
Q4 		$711K Buy
18,003
+5,739
+47% +$215K 0.05% 335
2013
Q3 		$437K Buy
12,264
+690
+6% +$24.3K 0.04% 387
2013
Q2 		$380K Buy
+11,574
New +$385K 0.04% 377

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
VCM
Virtue Capital Management Brentwood, Tennessee $749M AUM 40.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIC
Concord Investment Counsel Irvine, California $366M AUM 38.82% 1-Year Est. Return

Cetera Advisor Networks's IHE Position: Q1 2024 in Review

Cetera Advisor Networks increased its iShares US Pharmaceuticals ETF (IHE) stake by 7.1% in Q1 2024, buying an estimated $34.4K and bringing the position to 7,889 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #1888.

Cetera Advisor Networks first reported a position in IHE in Q2 2013 and has held it in 44 quarters since. The position peaked at $2.4M in Q4 2015. 143 funds tracked by Wall St. Rank hold IHE as of Q1 2024.

  • Cetera Advisor Networks held 7,889 shares of iShares US Pharmaceuticals ETF worth $536K as of Q1 2024.
  • Cetera Advisor Networks bought 521 iShares US Pharmaceuticals ETF shares in Q1 2024, an estimated $34.4K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1888 holding.
  • Cetera Advisor Networks first reported a position in iShares US Pharmaceuticals ETF in Q2 2013 and has held it in 44 quarters since.
  • Cetera Advisor Networks's iShares US Pharmaceuticals ETF position peaked at $2.4M in Q4 2015.
  • 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.